Oren Levy, PhD

Chief Executive Officer, Co-Founder

Therapeutic Areas

Drug	Indication	Phase
Break Wave	Fragmentation of kidney stones	Approved
Stone Clear	Repositioning of post-lithotripsy kidney stone fragments	Unknown